These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15976601)

  • 1. Factors that influence the cost effectiveness of gonorrhea screening in emergency departments.
    Gift TL; Irwin KL
    Sex Transm Dis; 2005 Jul; 32(7):437-8. PubMed ID: 15976601
    [No Abstract]   [Full Text] [Related]  

  • 2. The cost effectiveness of gonorrhea screening in urban emergency departments.
    Aledort JE; Hook EW; Weinstein MC; Goldie SJ
    Sex Transm Dis; 2005 Jul; 32(7):425-36. PubMed ID: 15976600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the routine, occupation-based gonorrhea and syphilis screening program in Moscow, Russia: an analysis of sexually transmitted infection prevalence and cost-effectiveness.
    Kourbatova EV; Akovbyan VA; Chesson HW; Lytkina IN; Dmitriev GA; Tikhonova LI; Koubanova AA; Petukhova II; Latypova MF; Aboymova OA; Lewis JS; Ryan CA; Shakarishvili A
    Sex Transm Dis; 2008 May; 35(5):453-60. PubMed ID: 18434940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of five strategies for gonorrhea and chlamydia control among female and male emergency department patients.
    Mehta SD; Bishai D; Howell MR; Rothman RE; Quinn TC; Zenilman JM
    Sex Transm Dis; 2002 Feb; 29(2):83-91. PubMed ID: 11818893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of screening strategies for Gonorrhea among females in private sector care.
    Bernstein KT; Mehta SD; Rompalo AM; Erbelding EJ
    Obstet Gynecol; 2006 Apr; 107(4):813-21. PubMed ID: 16582117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit-cost analysis of screening. A comparison of tests for gonorrhea.
    Goddeeris JH; Bronken TP
    Med Care; 1985 Nov; 23(11):1242-55. PubMed ID: 3934472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for pharyngeal gonorrhea in adolescents. A reexamination.
    Roochvarg LB; Lovchik JC
    J Adolesc Health; 1991 May; 12(3):269-72. PubMed ID: 1905155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of universal screening for chlamydia and gonorrhea in US jails.
    Kraut-Becher JR; Gift TL; Haddix AC; Irwin KL; Greifinger RB
    J Urban Health; 2004 Sep; 81(3):453-71. PubMed ID: 15273268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An economic evaluation of a school-based sexually transmitted disease screening program.
    Wang LY; Burstein GR; Cohen DA
    Sex Transm Dis; 2002 Dec; 29(12):737-45. PubMed ID: 12466713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility and cost of Chlamydia trachomatis and Neisseria gonorrhoeae screening of a male infertility population.
    Domes T; Lo KC; Grober ED; Mullen JB; Mazzulli T; Jarvi K
    Fertil Steril; 2012 Feb; 97(2):299-305. PubMed ID: 22192351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Eligibility Criteria on Participant Enrollment for a Randomized Clinical Trial of Gonorrhea Treatment.
    Long JE; Wierzbicki MR; Hook EW
    Sex Transm Dis; 2017 Jun; 44(6):362-364. PubMed ID: 28499287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of chlamydia and gonorrhea screening criteria: San Francisco sexually transmitted disease clinic: 1997 to 1998.
    Ciemins EL; Kent CK; Flood J; Klausner JD
    Sex Transm Dis; 2000 Mar; 27(3):165-7. PubMed ID: 10726651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should women be tested for gonococcal infection of the cervix during routine gynecologic visits? An economic appraisal.
    Phillips RS; Safran C; Aronson MD; Taylor WC
    Am J Med; 1989 Mar; 86(3):297-302. PubMed ID: 2493192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using patient-provided information to refine sexually transmitted infection screening criteria among women presenting in the emergency department.
    Jenkins WD; Kovach R; Wold BJ; Zahnd WE
    Sex Transm Dis; 2012 Dec; 39(12):965-7. PubMed ID: 23191951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Questioning the value of screening for gonorrhoea in symptomless heterosexual men.
    Pittrof R; Hitchings S; FitzGerald M
    Int J STD AIDS; 2009 Nov; 20(11):741-4. PubMed ID: 19854882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cost-effectiveness of Alcohol Screening, Brief Intervention, and Referral to Treatment (SBIRT) in Emergency and Outpatient Medical Settings.
    Barbosa C; Cowell A; Bray J; Aldridge A
    J Subst Abuse Treat; 2015 Jun; 53():1-8. PubMed ID: 25648375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rectal gonorrhea. Cost-benefit analysis of the value of anal canal cultures].
    Wulf HC
    Ugeskr Laeger; 1979 Nov; 141(46):3168-70. PubMed ID: 118563
    [No Abstract]   [Full Text] [Related]  

  • 18. Gonorrhea case-finding among asymptomatic men seeking ambulatory care: a cost effectiveness analysis.
    Pappius EM; Komaroff AL; Vosseler MG; Braun P; Sherman H
    Sex Transm Dis; 1984; 11(3):123-30. PubMed ID: 6438815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications for laboratory testing of gonorrhea. New recommendations from the Working Group against Gonorrhea].
    Aavitsland P
    Tidsskr Nor Laegeforen; 1996 Jun; 116(17):2017-21. PubMed ID: 8766644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incremental cost of screening, diagnosis, and treatment of gonorrhea and chlamydia in a family planning clinic.
    Begley CE; McGill L; Smith PB
    Sex Transm Dis; 1989; 16(2):63-7. PubMed ID: 2500721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.